(NYSE: WAT) Waters's forecast annual revenue growth rate of 18.26% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.4%.
Waters's revenue in 2026 is $4,644,249,000.On average, 27 Wall Street analysts forecast WAT's revenue for 2026 to be $641,756,661,052, with the lowest WAT revenue forecast at $620,240,324,743, and the highest WAT revenue forecast at $692,943,926,883. On average, 27 Wall Street analysts forecast WAT's revenue for 2027 to be $706,796,910,534, with the lowest WAT revenue forecast at $669,757,372,687, and the highest WAT revenue forecast at $751,499,801,039.
In 2028, WAT is forecast to generate $750,124,327,485 in revenue, with the lowest revenue forecast at $705,126,692,647 and the highest revenue forecast at $824,498,147,512.